<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01959256</url>
  </required_header>
  <id_info>
    <org_study_id>VIVID</org_study_id>
    <nct_id>NCT01959256</nct_id>
  </id_info>
  <brief_title>Visual Perceptual Learning for the Treatment of Visual Field Defect</brief_title>
  <acronym>VIVID</acronym>
  <official_title>Visual Perceptual Learning for the Treatment of Visual Field Defect</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the hypothesis whether visual field defect caused by chronic stroke
      could be improved by visual perceptual learning. The secondary hypothesis is that improvement
      of visual field defect would be accompanied by connectivity changes in visual networks. In
      addition, investigators will evaluate whether improvement of visual field defect could
      achieve improvement of subjective visual function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design: A PROBE (Prospective, Randomized, Open-label, Blinded-endpoint) design

      Methods:

        1. Visual perceptual learning (VPL) group

             1. Visual perceptual learning (24 times for 2 months, 3 times per week) in visual
                field defect areas

             2. At baseline and post-VPL evaluations (2 months after): Structural &amp; Functional
                MRIs, Visual field tests, Visual evoked potential, Visual cognitive tests,
                Subjective visual function questionnaires

        2. Control group

             1. At baseline and 2-months later: No VPL, Structural &amp; Functional MRIs, Visual field
                tests, Visual evoked potential, Visual cognitive tests, Subjective visual function
                questionnaires

             2. Visual perceptual learning after 2-month follow-up evaluation (24 times for 2
                months, 3 times per week)

           (The patients who were stratified by age (over 65 years old or not) and degree of visual
           field defect (quadrantanopia or complete hemianopia) will be randomly assigned into the
           learning and control group.)

        3. Investigations

             1. Improvement of visual field test scores between VPL group and control group

             2. Analysis of brain network changes in MRI data

             3. Correlation analysis of improvement of visual field defect and MRI data

             4. Correlation analysis of improvement of visual field defect and visual evoked
                potential (VEP) data

             5. Correlation analysis of improvement of visual field defect and neuropsychological
                data
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of visual field scores in visual field defect areas</measure>
    <time_frame>At 2 months (plus or minus 7 days) after baseline evaluation</time_frame>
    <description>Improvement of mean deviation scores in defected areas by Humphrey 750i Field test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance of visual perceptual learning</measure>
    <time_frame>At 2 months (plus or minus 7 days) after baseline evaulation</time_frame>
    <description>Performance (scores) of visual perceptual learning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Connectivity changes in MRI</measure>
    <time_frame>Between baseline and 2 months (plus or minus 7 days) after</time_frame>
    <description>Functional connectivity changes in resting-state functional MRI
Structural connectivity changes in diffusion tensor imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of visual field score in whole visual field area</measure>
    <time_frame>At 2 months (plus or minus 7days) after baseline evaluation</time_frame>
    <description>Improvement of mean deviation scores in whole visual field by Humphrey 750i Field test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of subjective visual function</measure>
    <time_frame>At 2 months (plus or minus 7days) after baseline evaluation</time_frame>
    <description>Change in Korean version of National Eye institute Visual Functioning Questionnaire-25 (NEI-VFQ-25)
Change of subjective visual field area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of visual evoked potential</measure>
    <time_frame>Between baseline and 2 months (plus or minus 7 days) after</time_frame>
    <description>Changes between baseline and 2 months after in half-field visual evoked potential (VEP) data</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Stroke</condition>
  <condition>Visual Field Defect</condition>
  <arm_group>
    <arm_group_label>Learning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Visual perceptual learning (VPL) group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Visual perceptual learning</intervention_name>
    <description>24 times of training for visual perceptual learning</description>
    <arm_group_label>Learning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient has chronic stroke more than 6 months after onset.

          2. The patient has visual field defect (Quadrantanopia or Hemianopia).

          3. The patient has corrected eyesight 0.7 or above.

        Exclusion Criteria:

          1. The patient has contraindication to MRI scan.

          2. The patient has cognitive impairment (Mini-Mental Status Exam score &lt;24).

          3. The patient has ophthalmologic diseases (e.g., glaucoma, cataract).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong-Wha Kang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dong-Wha Kang, MD, PhD</last_name>
    <phone>82-2-3010-3440</phone>
    <email>dwkang@amc.seoul.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong-Wha Kang, MD, PhD</last_name>
      <phone>82-2-3010-3440</phone>
      <email>dwkang@amg.seoul.kr</email>
    </contact>
    <investigator>
      <last_name>Dong-Wha Kang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>January 21, 2015</last_update_submitted>
  <last_update_submitted_qc>January 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Dong-Wha Kang</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Visual Field Defect</keyword>
  <keyword>Visual perceptual learning</keyword>
  <keyword>Brain connectivity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

